(Q39251767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

0 references

0 references

placebo-controlled trial

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

M Falah

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

C Madsen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

J V Holbech

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

19 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

published in

European Journal of Pain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

860-869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

Baclofen in the treatment of cerebral palsy.

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Specific effect of levetiracetam in experimental human pain models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Levetiracetam in spinal cord injury pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Lamotrigine in spinal cord injury pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

The evidence for pharmacological treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Anticonvulsant drugs in primary headaches prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Levetiracetam for phasic spasticity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Translation of symptoms and signs into mechanisms in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Levetiracetam in the treatment of neuropathic pain: three case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

A novel tool for the assessment of pain: validation in low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Acute and chronic pain syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Effect of levetiracetam on the postmastectomy pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1532-2149.2011.00073.X

10.1002/J.1532-2149.2011.00073.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22337561%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference